The study was published on April 20, 2020, in The Journal of Clinical Investigation.
According to Steven L. Teitelbaum, MD, the principal investigator of the study and Wilma and Roswell Messing Professor of Pathology & Immunology, their study has developed a proof of concept that it is possible to regulate weight gain by modulating the activity of the inflammatory cells.
He adds that it might work in several ways, but their team believed that it might be able to control obesity and its complications by managing inflammation better.
If this works, and if it’s marketed correctly, then in America the potential profits could be super-sized. O, the cheap, no wait approach: eat less, walk more.